Page last updated: 2024-08-26

diacetyldichlorofluorescein and adenosine

diacetyldichlorofluorescein has been researched along with adenosine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanno, M; Mori, S; Ohkohchi, N; Orii, T; Satomi, S; Taguchi, Y; Terashima, T1
Lasley, RD; Mentzer, RM; Narayan, P1
Lu, Y; Marucha, PT; Sroussi, HY; Villines, D; Zhang, QL1

Other Studies

3 other study(ies) available for diacetyldichlorofluorescein and adenosine

ArticleYear
Lipid peroxidation of parenchymal and nonparenchymal hepatocytes during cold preservation and after reoxygenation in rats.
    Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 2

    Topics: Adenosine; Allopurinol; Animals; Fluoresceins; Fluorescent Dyes; Glutathione; Hypertonic Solutions; Insulin; Kinetics; Lipid Peroxidation; Lipid Peroxides; Liver; Luminescent Measurements; Male; Organ Preservation Solutions; Raffinose; Rats; Rats, Wistar; Solutions; Time Factors; Tissue Preservation

1993
Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.
    Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:1

    Topics: Adenosine; Aniline Compounds; Animals; Calcium; Decanoic Acids; Drug Synergism; Fluoresceins; Fluorescent Dyes; Glyburide; Heart Ventricles; Hydroxy Acids; Ion Transport; Male; Microscopy, Fluorescence; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Oxidation-Reduction; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Purinergic P1; Xanthenes; Xanthines

2001
S100A8 and S100A9 inhibit neutrophil oxidative metabolism in-vitro: involvement of adenosine metabolites.
    Free radical research, 2010, Volume: 44, Issue:4

    Topics: Adenosine; Adenosine Deaminase; Calgranulin A; Calgranulin B; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Neutrophil Activation; Neutrophils; Oxidation-Reduction; Protein Kinase C; Purinergic P1 Receptor Antagonists; Reactive Oxygen Species; Receptors, Purinergic P1; Recombinant Proteins; Time Factors

2010